Endoscopic workup in pancreatic cancer
- PMID: 37737888
- PMCID: PMC11487006
- DOI: 10.1097/JS9.0000000000000777
Endoscopic workup in pancreatic cancer
Abstract
Pancreatic cancer is a highly lethal disease with a rising incidence. It is projected to become the second-leading cause of cancer-related mortality by 2030. The staging of pancreatic cancer can be broadly categorized into three groups: resectable cancers, locally advanced or borderline resectable cancers, and metastatic cancers. Endoscopy plays a crucial role in the management of pancreatic cancer for the establishment of the diagnosis, for the palliation of symptoms due to biliary and/or gastric outlet obstructions, and more recently, for the palliative ablation of cancer. The objective of this review is to provide an overview of the endoscopic evaluation and management of patients with pancreatic cancer. It will specifically cover the diagnostic approach utilizing endoscopic ultrasound, palliative interventions such as endoscopic retrograde cholangiopancreatography, and the emerging field of tumor debulking through radiofrequency ablation.
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
Dr Arnelo is co-PI of a Boston Scientific-sponsored study of the use of intraoperative pancreatoscopy in IPMN patients. Dr Arnelo is a consultant to Boston Scientific and Ambu. Dr Valente is a consultant for Boston Scientific.
References
-
- Rahib L, Smith BD, Aizenberg R, et al. . Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 2014;74:2913–2921. - PubMed
-
- Del Chiaro M, Valente R, Arnelo U. Neoadjuvant treatment in locally advanced and borderline resectable pancreatic cancer vs primary resectable pancreatic cancer. JAMA Surg 2017;152:1057. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical